circulating tumour cells (CTCs)

Joint ventures and alliances

Biolidics enters into collaboration agreement with Genome Institute of Singapore

SINGAPORE (Sept 10): Biolidics has entered into an agreement with the Genome Institute of Singapore (GIS) to collaborate and develop a new and innovative liquid biopsy test in the field of circulat

Joint ventures and alliances

Biolidics in partnership to expand into China cancer diagnostics market

SINGAPORE (June 25): Medical technology company Biolidics has entered into a partnership with Zhongshan TopGene Medical Laboratory Co to develop and commercialise laboratory-developed tests (LDTs)

Be informed of the stories that matter